Research & Development in
Hünenberg

Crypto International AG

Since 2018 · 11–20 empl.

The core activity of Crypto International AG is to provide comprehensive services for the operation and security of IT and communication infrastructures, with a particular focus on cybersecurity and encryption solutions. The company offers customer-specific services to meet the complex needs of international customers with high demands and ensure long-term business continuity.

NCMA Consulting GmbH

Since 2021 · 1–10 empl.

The core activity of NCMA Consulting GmbH is the provision of nonclinical management and advisory services to the life science industry, particularly for companies in the pharmaceutical, biopharmaceutical and medical technology sectors. The services include: Interim management and consulting, Strategic consulting and planning, Regulatory consulting and regulatory documentation, Management and reporting of nonclinical studies, Nonclinical safety assessments, Nonclinical efficacy and safety assessments for the medical technology industry, Toxicological assessments of extractables and leachables, Chemical characterization. The company also offers services as a Swiss Representative (CH-REP). The core activity of the company focuses on supporting companies in the development of (bio)pharmaceutical products and medical technology products, particularly in the areas of nonclinical development, regulatory affairs and safety assessments.

CompagOs AG

Since 2023 · 1–10 empl.

CompagOs AG develops the Bon3OID™ biohardware platform, which integrates engineered 3D‑bioprinted bone‑like tissue constructs with hardware for controlled mechanical loading to produce functional, multi‑modal readouts. The platform supports preclinical New Approach Methodologies (NAMs) and translational diagnostics research by enabling efficacy assessment and mechanistic insight in bone‑focused programs.

PPP Switzerland AG

Since 2022 · 1–10 empl.

The core activity of PPP Switzerland AG is the production of plant-based biomaterials, particularly plant extracts for the pharmaceutical, cosmetics and healthcare industries. The company operates fully automated and AI-controlled breeding farms to ensure sterile and efficient production. In addition, the company also offers research and development (R&D) services and has its own asset management for private, professional and institutional clients. Another business area is the marketing of Swiss land, particularly through the offer of plots of land under the SLand brand.

Bevel Labs GmbH

Since 2025 · 1–10 empl.

Bevel Labs GmbH is an agency focused on brand identity and visual brand management. The company provides services ranging from analysis and concept development to design, copy creation, project management, web design, and the production of advertising materials.

Helmut Fischer und Anni Walther Stiftung

Since 2008 · 1–10 empl.

INNORESE AG

Since 2009 · 1–10 empl.

Nanopos AG

Since 2013 · 1–10 empl.

Noxogen Therapeutics AG

Since 2016 · 1–10 empl.

Trichoma AG

Since 2018 · 1–10 empl.

Futura Minerals and Metals GmbH

Since 2019 · 1–10 empl.

SAFE4ALL

Since 2022 · 1–10 empl.